This signaling pathway, in part, inhibits mTOR via AMPK activation, and is believed to be responsible for the inhibition of breast cancer cell proliferation, suppression of the G1 phase of the cell cycle, and induction of apoptosis (Zakikhani et al., 2012; Kennedy et al., 2020). Here, MTOR is linked to breast carcinoma.